BD Posts Q3 Revenue Increase of 2 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Becton Dickinson today reported that its third-quarter revenues increased nearly 2 percent, but were up 5 percent on a currency-neutral basis.

The Franklin Lakes, NJ-based medical devices, diagnostics, and research products firm generated total revenues of $1.98 billion for the quarter ended June 30, compared to $1.95 billion for the third quarter of 2011. It missed analysts' consensus estimate of $2.02 billion.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genome sequencing study of Yakutian horses, tardigrade genome, and more.

A guest post at Retraction Watch discusses what funders can do to improve research reproducibility.

Researchers report in Nature this week that farming led to genomic adaptations in humans.

The FDA argues that it needs to evaluate the safety and efficacy of laboratory-developed tests, a proposal that divides Republicans.